Jensen R - Search Results

1

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JH. Schuster J, et al. Among authors: jensen r. Neuro Oncol. 2015 Jun;17(6):854-61. doi: 10.1093/neuonc/nou348. Epub 2015 Jan 13. Neuro Oncol. 2015. PMID: 25586468 Free PMC article. Clinical Trial.

2

Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma.

McCall T, Rao G, Jensen R. McCall T, et al. Among authors: jensen r. J Neurooncol. 2006 Nov;80(2):167-70. doi: 10.1007/s11060-006-9166-5. Epub 2006 Apr 28. J Neurooncol. 2006. PMID: 16645711

3

Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature.

Kan P, Gottfried ON, Blumenthal DT, Liu JK, Salzman KL, Townsend J, Jensen RL. Kan P, et al. J Neurooncol. 2006 Jul;78(3):249-53. doi: 10.1007/s11060-005-9022-z. J Neurooncol. 2006. PMID: 16773223 Review.

4

Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.

Majer M, Jensen RL, Shrieve DC, Watson GA, Wang M, Leachman SA, Boucher KM, Samlowski WE. Majer M, et al. Cancer. 2007 Sep 15;110(6):1329-37. doi: 10.1002/cncr.22905. Cancer. 2007. PMID: 17623835 Free article.

5

WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options.

Niazi TN, Jensen EM, Jensen RL. Niazi TN, et al. J Neurooncol. 2009 Feb;91(3):323-8. doi: 10.1007/s11060-008-9717-z. Epub 2008 Nov 1. J Neurooncol. 2009. PMID: 18974933 Review.

6

Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Jensen RL. Jensen RL. J Neurooncol. 2009 May;92(3):317-35. doi: 10.1007/s11060-009-9827-2. Epub 2009 Apr 9. J Neurooncol. 2009. PMID: 19357959 Review.

7

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.

Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: jensen r. J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720927 Clinical Trial.

8

Parafalcine lesions in the cancer patient: diagnostic dilemma--meningioma or metastatic lesion?

Mumert ML, Jensen EM, Jensen R. Mumert ML, et al. Among authors: jensen r, jensen em. J Neurooncol. 2010 Aug;99(1):135-9. doi: 10.1007/s11060-009-0104-1. Epub 2009 Dec 24. J Neurooncol. 2010. PMID: 20033754

9

Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme.

Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve DC. Anker CJ, et al. J Neurooncol. 2010 Jun;98(2):253-63. doi: 10.1007/s11060-010-0176-y. Epub 2010 Apr 10. J Neurooncol. 2010. PMID: 20383558

10

Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery.

Jensen RL, Jensen PR, Shrieve AF, Hazard L, Shrieve DC. Jensen RL, et al. Among authors: jensen pr. J Neurooncol. 2010 Jun;98(2):221-31. doi: 10.1007/s11060-010-0174-0. Epub 2010 May 12. J Neurooncol. 2010. PMID: 20461446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,894 results

Search Page

Filters